Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 28:536:215664.
doi: 10.1016/j.canlet.2022.215664. Epub 2022 Mar 26.

Macrophage inhibitory cytokine-1 in cancer: Beyond the cellular phenotype

Sakthivel Muniyan  1 , Ramesh Pothuraju  2 , Parthasarathy Seshacharyulu  2 , Surinder K Batra  3
Affiliations
Review

Macrophage inhibitory cytokine-1 in cancer: Beyond the cellular phenotype

Sakthivel Muniyan et al. Cancer Lett. .

Abstract

Despite technological advances in diagnostic abilities and improved treatment methods, the burden of cancers remains high, leading to significant morbidity and mortality. One primary reason is that cancer cell secretory factors modulate the tumor microenvironment, supporting tumor growth and circumvents anticancer activities of conventional therapies. Macrophage inhibitory cytokine-1 (MIC-1) is a pleiotropic cytokine elevated in various cancers. MIC-1 regulates various cancer hallmarks, including sustained proliferation, tumor-promoting inflammation, avoiding immune destruction, inducing invasion, metastasis, angiogenesis, and resisting cell death. Despite these facts, the molecular regulation and downstream signaling of MIC-1 in cancer remain elusive, partly because its receptor (GFRAL) was unknown until recently. Binding of MIC-1 to GFRAL recruits the coreceptor tyrosine kinase RET to execute its downstream signaling. So far, studies have shown that GFRAL expression is restricted to the brain stem and is responsible for MIC-1/GFRAL/RET-mediated metabolic disorders. Nevertheless, abundant levels of MIC-1 expression have been reported in all cancer types and have been proposed as a surrogate biomarker. Given the ubiquitous expression of MIC-1 in cancers, it is crucial to understand both upstream regulation and downstream MIC-1/GFRAL/RET signaling in cancer hallmark traits.

Keywords: Cancer; Cancer hallmarks; Immunosurveillance; MIC-1/GFRAL/RET signaling; Surrogate biomarker.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:

SKB is a founding member of Sanguine Diagnostics and Therapeutics, Inc. Other authors have no conflicts of interest.

Figures

Figure 1:
Figure 1:
Genomic regulation of Macrophage inhibitory cytokine-1 (MIC-1) in cancer cells. Evidence from the literature suggests that various factors induce MIC-1 in a context-dependent manner.
Figure 2:
Figure 2:
Macrophage inhibitory cytokine-1 (MIC-1) mediated cellular effects. MIC-1 association with cancer hallmarks traits through various biological features. The categories were masked (given in grey) where it lacks scientific evidence. The illustration were recreated based on a recent review by Hanahan [23].
Figure 3:
Figure 3:
A schematic representation of the Macrophage inhibitory cytokine-1 (MIC-1) signaling pathway in cell proliferation. MIC-1 has been shown to have dualistic regulation of MIC-1 signaling. The protumor function of MIC-1 is shown mainly through the activation of ERK and AKT in cancer cells and the antitumor function is mainly through p53-dependent and independent mechanisms..
Figure 4:
Figure 4:
Autocrine and paracrine effects of Macrophage inhibitory cytokine-1 (MIC-1) in cancer cell invasion and metastasis. Tumor cell-derived MIC-1 could induce autocrine action at the primary tumor site and paracrine action in tumor microenvironment and in metastasis.
Figure 5:
Figure 5:
Macrophage inhibitory cytokine-1 (MIC-1) mediated action on endothelial cells. Under normoxic conditions, MIC-1, possibly through GFRAL, induces CCN2 and inhibits αVβ3 integrin clusteringand prevent endothelial cell proliferation. In hypoxic conditions, MIC-1 could inhibit P53 which then stabilizes the HIF-1α and induces VEGF expression.
See this image and copyright information in PMC

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F, Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries, CA Cancer J Clin, 71 (2021) 209–249. - PubMed
    1. Mimeault M, Batra SK, Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer, J Cell Physiol, 224 (2010) 626–635. - PMC - PubMed
    1. Tsai VWW, Husaini Y, Sainsbury A, Brown DA, Breit SN, The MIC-1/GDF15-GFRAL Pathway in Energy Homeostasis: Implications for Obesity, Cachexia, and Other Associated Diseases, Cell Metab, 28 (2018) 353–368. - PubMed
    1. Zhao L, Lee BY, Brown DA, Molloy MP, Marx GM, Pavlakis N, Boyer MJ, Stockler MR, Kaplan W, Breit SN, Sutherland RL, Henshall SM, Horvath LG, Identification of candidate biomarkers of therapeutic response to docetaxel by proteomic profiling, Cancer Res, 69 (2009) 7696–7703. - PubMed
    1. Zhang Y, Hua W, Niu LC, Li SM, Wang YM, Shang L, Zhang C, Li WN, Wang R, Chen BL, Xin XY, Zhang YQ, Wang J, Elevated growth differentiation factor 15 expression predicts poor prognosis in epithelial ovarian cancer patients, Tumour Biol, 37 (2016) 9423–9431. - PubMed